SLS SELLAS Life Sciences Group, Inc.
Company Analysis
Latest News
SELLAS Life Sciences Amends Executive Severance and Change of Control Agreements
SELLAS Life Sciences Group has entered into amended employment and severance agreements with its President and CEO, Dr. Angelos Stergiou; CFO, John Burns; and...
🟢 SLS makes sharp 10.9% jump
SLS is trading at $10.17, up 10.9% versus the comparison close of $9.17 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SLS is trading 5.5% up today as traders position for Phase 3 REGAL trial results
SLS is trading 5.5% up today at $9.67 as traders continue positioning around binary Phase 3 REGAL trial results and elevated volatility typical for pre-readout...
🟢 SLS is trading 6.8% up today, extending a multi-day rally on momentum
SLS is trading 6.8% up at $9.11 today, extending a sharp multi-day rally despite a lack of fresh company-specific catalysts. • The stock has climbed...
SLS Shareholders Approve 20M Share Increase to Equity Plan at Annual Meeting
SELLAS Life Sciences Group, Inc. announced the voting results from its Annual Meeting of Stockholders held on June 16, 2026. All five proposals were approved...
🟢 Sellas Life Sciences Group Inc surges 5.6% following $154.6M shelf filing and increased borrow rates
- Sellas Life Sciences Group Inc. has filed a $154.6 million shelf registration for up to 20,000,000 common shares, signaling future capital raising for its...